These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3404958

  • 21. [Risk factors of proliferative vitreoretinopathy].
    Szymański A, Gierek-Lapińska A, Formińska-Kapuścik M, Gierek-Kalicka S.
    Klin Oczna; 1991; 93(10-11):295-6. PubMed ID: 1726494
    [Abstract] [Full Text] [Related]

  • 22. [Has the incidence of postoperative PVR in rhegmatogenous retinal detachment decreased?].
    Bonnet M, Guenoun S, Yaniali A, Fleury J, Hajjar C, Dumas C, Duquesne N, Semiglia R.
    J Fr Ophtalmol; 1996; 19(11):696-704. PubMed ID: 9033891
    [Abstract] [Full Text] [Related]

  • 23. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
    Dieudonné SC, La Heij EC, Diederen RM, Kessels AG, Liem AT, Kijlstra A, Hendrikse F.
    Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
    [Abstract] [Full Text] [Related]

  • 24. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
    Dieudonné SC, La Heij EC, Diederen R, Kessels AG, Liem AT, Kijlstra A, Hendrikse F.
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
    [Abstract] [Full Text] [Related]

  • 25. [Clinical risk factors for postoperative proliferative vitreoretinopathy (PVR). A prospective study].
    Rodríguez de la Rúa E, Martínez V, Aragón J, Sanabria RM, Giraldo A, Mayo A, Pastor JC, Miranda I, García Arumí J.
    Arch Soc Esp Oftalmol; 2003 Feb; 78(2):91-7. PubMed ID: 12647249
    [Abstract] [Full Text] [Related]

  • 26. Silicone oil tamponade for retinal detachment and delayed treatment of retinal tears.
    Zauberman H, Hemo I.
    Ophthalmic Surg; 1993 Sep; 24(9):600-3. PubMed ID: 8233333
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy.
    Rodriguez de la Rúa E, Pastor JC, Aragón J, Mayo-Iscar A, Martínez V, García-Arumí J, Giraldo A, Sanabria-Ruiz Colmenares MR, Miranda I.
    Curr Eye Res; 2005 Feb; 30(2):147-53. PubMed ID: 15814473
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.
    Kon CH, Occleston NL, Charteris D, Daniels J, Aylward GW, Khaw PT.
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1524-9. PubMed ID: 9660504
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy.
    Capeans C, Lorenzo J, Santos L, Suarez A, Copena MJ, Blanco MJ, Sánchez-Salorio M.
    Graefes Arch Clin Exp Ophthalmol; 1998 Jul; 236(7):481-5. PubMed ID: 9672792
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Horseshoe tears and proliferative vitreoretinopathy].
    Li C.
    Yan Ke Xue Bao; 1993 Dec; 9(4):196-9, 215. PubMed ID: 7957856
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.